Laboratory Corporation of America Holdings

Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than one million tests on approximately 400,000 samples each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing. Our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies.
Company Growth (employees)
Type
Public
HQ
Burlington, US
Founded
1976
Size (employees)
52,000 (est)+4%
Laboratory Corporation of America Holdings was founded in 1976 and is headquartered in Burlington, US

Key People at Laboratory Corporation of America Holdings

David P. King

David P. King

Chairman and Chief Executive Officer
Glenn A. Eisenberg

Glenn A. Eisenberg

Executive Vice President and Chief Financial Officer
Lance V. Berberian

Lance V. Berberian

Senior Vice President and Chief Information Officer
Lisa J. Uthgenannt

Lisa J. Uthgenannt

Chief Human Resources Officer

Laboratory Corporation of America Holdings Office Locations

Laboratory Corporation of America Holdings has offices in Burlington, , Birmingham, Tampa and in 86 other locations
Burlington, US (HQ)
531 S Spring St

Laboratory Corporation of America Holdings Metrics

Laboratory Corporation of America Holdings Financial Metrics

Revenue (2016)

$9.6 b

Revenue growth (2015-16), %

11%

Net income (2016)

$733.2 m

Market capitalization (21-Mar-2017)

$14.7 b

Closing share price (21-Mar-2017)

$143.6

Cash (31-Dec-2013)

$404 m
Laboratory Corporation of America Holdings's current market capitalization is $14.7 b.
Laboratory Corporation of America Holdings's revenue was reported to be $9.6 b in FY, 2016 which is a 11.1% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$5.8 b$6 b$8.7 b$9.6 b

Revenue growth, %

4%44%11%

Cost of goods sold

$3.6 b

Gross profit

$2.2 b

Gross profit Margin, %

38%

EBIT

$990.9 m

EBIT margin, %

17%

Pre tax profit

$915.6 m

Net Income

$575.4 m$512.6 m$438 m$733.2 m
FY, 2013

Cash

$404 m

Current Assets

$1.4 b

PP&E

$707.4 m

Total Assets

$7 b

Accounts Payable

$304.5 m

Total Debt

$111.3 m

Current Liabilities

$735.7 m

Additional Paid-in Capital

Retained Earnings

$3.4 b

Debt to Assets Ratio

0 x
FY, 2013

Net Income

$575.4 m

Accounts Receivable

($67.5 m)

Inventories

($15.3 m)

Accounts Payable

$60.8 m

Cash From Operating Activities

$818.7 m

Capital Expenditures

($202.2 m)

Cash From Investing Activities

($359.6 m)

Long-term Borrowings

($412 m)

Cash From Financing Activities

($518.3 m)

Free Cash Flow

$1 b

Laboratory Corporation of America Holdings Operating Metrics

FY, 2016

Patient Service Centers

1.75 k

Countries

60

Laboratory Corporation of America Holdings Market Value History

Laboratory Corporation of America Holdings Revenue Breakdown

Laboratory Corporation of America Holdings Job Categories

Laboratory Corporation of America Holdings Median Salaries

Source: 42 public H-1B filings from Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings Online Presence

Laboratory Corporation of America Holdings News

Laboratory Corporation of America Holdings Company Life

You may also be interested in